HMG-20993-12481
4 vaccinations
3 coded responses
51 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 088 / NJ
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
-
2021-03-26
Dose 2 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-18
-
2021-04-23
Survey response — day 28, dose 2MedDRA: Office visit, Rash, Rash pruritic, Specialist consultation — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Itchy rash down face and neck that started 3 days after shot and have yet to subside · Healthcare visit (other): Visit to dermatologist and GPMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-30
- 2021-05-07
-
2021-06-25
Survey response — 3 months, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Skin rashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-30
- 2021-09-26
-
2021-11-23
Dose 3 — Moderna
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-14
-
2021-12-21
Survey response — day 28, dose 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Stuffy/runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
- 2022-01-04
- 2022-02-23
- 2022-05-26
-
2022-11-19
Dose 4 — Moderna
- 2022-11-19
-
2022-11-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
- 2022-11-21
- 2022-11-22
- 2022-11-23
- 2022-11-24
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2022-12-17
- 2022-12-24
- 2022-12-31
- 2023-02-18
- 2023-05-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Moderna | No |
| 4 | 2022-11-19 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — day 28, dose 2
Symptoms: Itchy rash down face and neck that started 3 days after shot and have yet to subside
Healthcare visit (other): Visit to dermatologist and GP
Release 9 — 3 months, dose 2
Symptoms: Skin rashes
Release 10 — day 28, dose 3
Symptoms: Stuffy/runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release